Dr. Hui Yang is presently working as Professor in the Department of Gastroenterology, Guangzhou Medical University, China. Until 2010 he worked as postdoctoral fellow at University of Kansas Medical Center, United States. He is the professional member in Chinese Society of Hepatology. He is serving as an editorial board member, reviewer for some international Gastroenterology journals. He has number of publication in related to liver cancer.
Dr. Hui Yang’s research interest includes molecular mechanisms of HDACi antitumor effects, pathogenesis of the liver diseases such as fatty liver, fibrosis, cirrhosis, human hepatocellular carcinoma, and Identification of potential therapeutic targets in the prevention and treatment of liver disease.
